期刊文献+

卡托普利对HHcy大鼠动脉平滑肌增生拮抗作用 被引量:5

原文传递
导出
出处 《中国公共卫生》 CAS CSCD 北大核心 2009年第3期345-345,共1页 Chinese Journal of Public Health
基金 长春科技计划项目(2006085)
  • 相关文献

参考文献4

二级参考文献32

  • 1郝文君,白小涓.兔动脉粥样硬化不同阶段一氧化氮及合酶观察[J].中国公共卫生,2005,21(4):444-446. 被引量:8
  • 2刘伟峰,张步延,黄文增,关红菁.高同型半胱氨酸血症致血管炎症作用[J].中国动脉硬化杂志,2005,13(4):464-466. 被引量:32
  • 3胡泽平,王邦宁.血管内皮功能不全与高血压研究进展[J].医学综述,2007,13(4):255-257. 被引量:12
  • 4朱栓立 芦海 乔华.高血压病患者血浆同型半胱氨酸水平与颈动脉内中膜厚度的相关性[J].中华心血管病杂志,2001,29:197-197.
  • 5Furchgott RF,Zawadzki JV.The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine[J].Nature,1980,288(5789):373-376.
  • 6Perticone F,Ceravolo R,Pujia A,et al.Prognostic significance of endothelial dysfunction in hypertensive patients[J].Circulation,2001,104(2):191-196.
  • 7Johnson FK,Johnson RA,Peyton KJ,et al.Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension[J].Am J Physiol Regul Integr Comp Physiol,2005,288 (4):R1057-1062.
  • 8Klingbeil AU,John S,Schneider MP,et al.Effect of AT1 receptorblockade on endothelial function in essential hypertension[J].Am J Hypertens,2003,16(2):123-128.
  • 9Nitenberg A,Chemla D,Antony I.Epicardial coronary artery constriction to cold pressor test is predictive of cardiovascular events in hypertensive patients with angiographically normal coronary arteries and without other major coronary risk factor[J].Atherosclerosis,2004,173 (1):115-123.
  • 10Xenos ES,Stevens SL,Freeman MB,et al.Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells[J].Ann Vasc Surg,2005,19(3):386-392.

共引文献15

同被引文献29

  • 1Welch GN,Loscalzo JN.Homocysteine and atherothrombosis[J].N Engl J Med,1998,338(15):1042-1045.
  • 2Boushey CJ,Beresford SAA,Omenm BS,et al.A quantitative assessmentofplasma homcysteine as a risk factor forvasculardisease[J].JAMA,1995,274:1049-1057.
  • 3GuoH,Lee JD,Xing Y,et al.Changes of homocysteine levels and arterial endothelia function in patientswith high risk of coronary artery disease after 6-month folic acid supplementation[J].Acta Cardio,l 2004,59(5):503-506.
  • 4Kaare Harald Bonaa,M.D.Ph.D.Inger Njolstad,M.D.Ph.D.Per Magne Ueland,M.D,Ph.D.Henrik Schirmer,M.D.Ph.D.Aage Tverdal,Ph.D,Terje Steigen,M.D.Ph.D.Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction[J].The new england journal of medicine,2006,354:1578-1588.
  • 5Welch GN, Loscalzo JN. Homocysteine and atherothrombosis[J ]. NEngl Jmed, 1998, 338(15) : 1042 - 1045.
  • 6Boushey CJ, Beresford SAA, Omenm BS, et al. A quantitative assessmentofplasma homcysteine as a risk factor forvasculardisease [J]. JAMA, 1995, 274 : 1049 - 1057.
  • 7Guo H, Lee JD, Xing Y, et al. Changes of homocysteine levels and arterial endothelia function in patientswith high risk of coronary artery disease after6- month folic acid supplementation[ J ]. Acta Cardio, 2004, 59(5) : 503 - 506.
  • 8Kaare Harald Bonaa, Inger Njolstsd, Per Magne Ueland, et al. Homocysteine Lowering and Cardiova- scular Events after Acute Myocardial Infarction[J]. The new england journal of medicine, 2006, 354 : 1578 - 1588.
  • 9陆再英,钟南山.内科学[M].7版北京:人民卫生出版社.2008:394.
  • 10Goldstein LB,Bushnell CD,A dams RJ,et al.Guidelines for the primary prevention of stroke:a guideline for healthcare prefessionals from the American Heart Association/American Stroke Association.Stroke,2011,42(2):517-584.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部